United States · Health Care · USD (Millions) · Annual
Key financials
USD|Millions
ROE
9.03%
2026 (actual)
ROA
7.07%
2026 (actual)
Gross Margin
65.76%
2026 (actual)
Net Margin
14.97%
2026 (actual)
Total Assets
$2,586.73M
2026 (actual)
Net Income
$181.86M
2026 (actual)
Valuation
$23,213.52M
2026 (actual)
Stock Price
$148.03
Historical & projected performance
USD|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-5.8 pt
Company
Sector average (own scale)
ROA
-4.5 pt
Company
Gross Margin
-13.2 pt
Company
Sector average
Net Margin
-10.3 pt
Company
Total Assets
+45.2%
Company
Sector average
Net Income
-49.2%
Company
Valuation
-49.2%
Company
Sector average (own scale)
Stock Price
-49.2%
Company
Sector average (own scale)
Amounts in USD (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for BIO-TECHNE Corp? It covers the balance sheet, income statement, cash flow and Equlion model projections.